Macular edema secondary to retinal vein occlusion
Showing 26 - 50 of >10,000
Anti-VEGF in Real-world
Recruiting
- Neovascular Age-related Macular Edema
- +5 more
- Ranibizumab
- +2 more
-
Beijing, Beijing, ChinaWen-Bin Wei
Feb 2, 2022
Age-Related Macular Degeneration, Neovascular Age-related Macular Degeneration, Wet Macular Degeneration Trial in Springfield,
Active, not recruiting
- Age-Related Macular Degeneration
- +4 more
- bevacizumab
-
Springfield, Illinois
- +2 more
Dec 6, 2021
Neovascular Age-related Macular Degeneration, Age-related Macular Degeneration, Diabetic Retinopathy Trial in Durham (AngioVue
Terminated
- Neovascular Age-related Macular Degeneration
- +4 more
- AngioVue SD-OCT
-
Durham, North CarolinaDuke Eye Center
Mar 29, 2022
Macular Edema, Retinal Vein Occlusion Trial in Damascus (suprachoroidal injection of Triamcinolone Acetonide.)
Completed
- Macular Edema
- Retinal Vein Occlusion
- suprachoroidal injection of Triamcinolone Acetonide.
-
Damascus, Syrian Arab RepublicAl Mouwasat University Hospital, Department of Ophthalmology
Aug 31, 2021
Central Retinal Vein Occlusion With Macular Edema Trial in Tanta (Ziv-Aflibercept 25 MG/ML [Zaltrap])
Completed
- Central Retinal Vein Occlusion With Macular Edema
- Ziv-Aflibercept 25 MG/ML [Zaltrap]
-
Tanta, El Gharbia, EgyptTanta University
Oct 4, 2021
Diabetic Macular Edema, Vogt Koyanagi Harada Disease, Retinal Vein Occlusion Trial in Banha (Suprachoroidal triamcinolone
Recruiting
- Diabetic Macular Edema
- +2 more
- Suprachoroidal triamcinolone acetonide injection
-
Banhā, Benha, EgyptAhmed Abdelshafy Tabl
Aug 9, 2022
Collateral Damage From COVID-19 Pandemic Observed in Patients
Completed
- Age Related Macular Degeneration
- +2 more
- Questionnaire
- Data collection up to 1 year
-
Ecully, France
- +3 more
Mar 2, 2022
Retinal Vein Occlusion, Macula Edema Trial in United States (TLC399 (ProDex))
Completed
- Retinal Vein Occlusion
- Macula Edema
- TLC399 (ProDex)
-
Phoenix, Arizona
- +19 more
Nov 24, 2021
Wet Age-related Macular Degeneration, Retinal Vein Occlusion, Diabetic Macular Edema Trial in United States (KSI-301)
Terminated
- Wet Age-related Macular Degeneration
- +2 more
-
Phoenix, Arizona
- +10 more
Nov 1, 2022
Age Related Macular Degeneration, Diabetic Macular Edema, Retinal Vein Occlusion Trial in Toronto (Intravitreal aflibercept)
Recruiting
- Age Related Macular Degeneration
- +3 more
- Intravitreal aflibercept
-
Toronto, Ontario, Canada
- +1 more
Apr 27, 2021
Age Related Macular Degeneration, Diabetic Macular Edema, Macular Edema Trial in Toronto (Intravitreal ranibizumab)
Recruiting
- Age Related Macular Degeneration
- +3 more
- Intravitreal ranibizumab
-
Toronto, Ontario, Canada
- +1 more
Apr 27, 2021
Age-related Macular Degeneration, Neovascular Age-related Macular Degeneration, Wet Macular Degeneration Trial in United States
Completed
- Age-related Macular Degeneration
- +4 more
- bevacizumab
-
Tucson, Arizona
- +19 more
Nov 16, 2021
Macula Edema, Retinal Vein Occlusion Trial in Sydney (Ellex Integre NIR laser)
Recruiting
- Macula Edema
- Retinal Vein Occlusion
- Ellex Integre NIR laser
-
Sydney, New South Wales, AustraliaMacular Research Group, Save Sight Institute, The University of
Apr 13, 2021
Branch Retinal Vein Occlusion With Macular Edema Trial in Stockholm (Aflibercept Injection [Eylea], Ranibizumab Injection
Recruiting
- Branch Retinal Vein Occlusion With Macular Edema
- Aflibercept Injection [Eylea]
- Ranibizumab Injection [Lucentis]
-
Stockholm, SwedenSt Eriks Eye Hospital
Dec 2, 2020
Central Retinal Vein Occlusion Trial in United States (aflibercept, bevacizumab)
Completed
- Central Retinal Vein Occlusion
-
Phoenix, Arizona
- +71 more
Jun 11, 2021
High Resolution Optical Coherence Tomography
Not yet recruiting
- Retinal Disease
- +15 more
- High-resolution optical coherence tomography (High-Res-OCT)
- Standard spectral domain OCT (SD-OCT)
-
Bern 3010, Bern, SwitzerlandDepartment of Ophthalmology, Bern University Hospital, Bern, 301
Nov 17, 2021
Age-related Macular Degeneration, Retinal Vein Occlusion, Diabetic Macular Edema Trial in Vienna (MacInfo presentation, Placebo
Recruiting
- Age-related Macular Degeneration
- +2 more
- MacInfo presentation
- Placebo presentation
-
Vienna, AustriaVienna Institute for Research in Ocular Surgery (VIROS), Hanusch
Jan 24, 2022
Glaucoma, Glaucoma Suspect, Diabetic Retinopathy Trial in Philadelphia (Free Eye Screenings, Enhanced Intervention, Usual Care)
Completed
- Glaucoma
- +12 more
- Free Eye Screenings
- +2 more
-
Philadelphia, PennsylvaniaWills Eye Glaucoma Service
Aug 19, 2022
Macular Edema Secondary to Retinal Vein Occlusion Trial in Worldwide (Aflibercept, VEGF Trap-Eye(Eylea, BAY86-5321)_higher dose,
Not yet recruiting
- Macular Edema Secondary to Retinal Vein Occlusion
- Aflibercept, VEGF Trap-Eye(Eylea, BAY86-5321)_higher dose
- +3 more
-
Fullerton, California
- +311 more
Apr 28, 2023
Central Retinal Vein Occlusion With Macular Edema Trial in Germany (Ranibizumab Injection, Laser photocoagulation)
Recruiting
- Central Retinal Vein Occlusion With Macular Edema
- Ranibizumab Injection
- Laser photocoagulation
-
Dresden, Germany
- +13 more
May 5, 2022
Central Retinal Vein Occlusion Trial in Worldwide (Aflibercept (Eylea, BAY86-5321))
Completed
- Central Retinal Vein Occlusion
- Aflibercept (Eylea, BAY86-5321)
-
Albury, New South Wales, Australia
- +41 more
Jun 19, 2020